|
1
|
Nanayakkara G, Viswaprakash N, Zhong J,
Kariharan T, Quindry J and Amin R: PPARγ activation improves the
molecular and functional components of I(to) remodeling by
angiotensin II. Curr Pharm Des. 19:4839–4847. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Subramanian V, Golledge J, Heywood EB,
Bruemmer D and Daugherty A: Regulation of peroxisome
proliferator-activated receptor-γ by angiotensin II via
transforming growth factor-β1-activated p38 mitogen-activated
protein kinase in aortic smooth muscle cells. Arterioscler Thromb
Vasc Biol. 32:397–405. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Angeloni C and Hrelia S: Quercetin reduces
inflammatory responses in LPS-stimulated cardiomyoblasts. Oxid Med
Cell Longev. 2012:8371042012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Takahashi K, Sasaki T, Mammoto A, Takaishi
K, Kameyama T, Tsukita S and Takai Y: Direct interaction of the Rho
GDP dissociation inhibitor with ezrin/radixin/moesin initiates the
activation of the Rho small G protein. J Biol Chem.
272:23371–23375. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bonni A, Brunet A, West AE, Datta SR,
Takasu MA and Greenberg ME: Cell survival promoted by the Ras-MAPK
signaling pathway by transcription-dependent and -independent
mechanisms. Science. 286:1358–1362. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Matsumura T, Kinoshita H, Ishii N, Fukuda
K, Motoshima H, Senokuchi T, Taketa K, Kawasaki S, Nishimaki-Mogami
T, Kawada T, et al: Telmisartan exerts antiatherosclerotic effects
by activating peroxisome proliferator-activated receptor-γ in
macrophages. Arterioscler Thromb Vasc Biol. 31:1268–1275. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Du K, Herzig S, Kulkarni RN and Montminy
M: TRB3: a tribbles homolog that inhibits Akt/PKB activation
by insulin in liver. Science. 300:1574–1577. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ohoka N, Yoshii S, Hattori T, Onozaki K
and Hayashi H: TRB3, a novel ER stress-inducible gene, is induced
via ATF4-CHOP pathway and is involved in cell death. EMBO J.
24:1243–1255. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Qi L, Heredia JE, Altarejos JY, Screaton
R, Goebel N, Niessen S, Macleod IX, Liew CW, Kulkarni RN, Bain J,
et al: TRB3 links the E3 ubiquitin ligase COP1 to lipid metabolism.
Science. 312:1763–1766. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Panicker SR, Sreenivas P, Babu MS,
Karunagaran D and Kartha CC: Quercetin attenuates monocyte
chemoattractant protein-1 gene expression in glucose primed aortic
endothelial cells through NF-kappaB and AP-1. Pharmacol Res.
62:328–336. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Meléndez GC, McLarty JL, Levick SP, Du Y,
Janicki JS and Brower GL: Interleukin 6 mediates myocardial
fibrosis, concentric hypertrophy, and diastolic dysfunction in
rats. Hypertension. 56:225–231. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kozomara A and Griffiths-Jones S: miRBase:
annotating high confidence microRNAs using deep sequencing data.
Nucleic Acids Res. 42:D68–D73. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Farazi TA, Hoell JI, Morozov P and Tuschl
T: MicroRNAs in human cancer. Adv Exp Med Biol. 774:1–20. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hoshino A, Matoba S, Iwai-Kanai E,
Nakamura H, Kimata M, Nakaoka M, Katamura M, Okawa Y, Ariyoshi M,
Mita Y, et al: p53-TIGAR axis attenuates mitophagy to exacerbate
cardiac damage after ischemia. J Mol Cell Cardiol. 52:175–184.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li YC, Liu YY, Hu BH, Chang X, Fan JY, Sun
K, Wei XH, Pan CS, Huang P, Chen YY, et al: Attenuating effect of
post-treatment with QiShen YiQi Pills on myocardial fibrosis in rat
cardiac hypertrophy. Clin Hemorheol Microcirc. 51:177–191.
2012.PubMed/NCBI
|
|
16
|
Hou J and Kang YJ: Regression of
pathological cardiac hypertrophy: signaling pathways and
therapeutic targets. Pharmacol Ther. 135:337–354. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lv D, Liu J, Zhao C, Sun Q, Zhou Q, Xu J
and Xiao J: Targeting microRNAs in pathological hypertrophy and
cardiac failure. Mini Rev Med Chem. 15:475–478. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li Y and Zhang Z: Computational biology in
microRNA. Wiley Interdiscip Rev RNA. 6:435–452. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liang Y, Qiu X, Xu RZ and Zhao XY:
Berbamine inhibits proliferation and induces apoptosis of KU812
cells by increasing Smad3 activity. J Zhejiang Univ Sci B.
12:568–574. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Eilat-Adar S, Sinai T, Yosefy C and Henkin
Y: Nutritional recommendations for cardiovascular disease
prevention. Nutrients. 5:3646–3683. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhong C, Luzhan Z, Genshan M, Jiahong W,
Xiaoli Z and Qi Q: Monocyte chemoattractant protein-1-2518 G/A
polymorphism, plasma levels, and premature stable coronary artery
disease. Mol Biol Rep. 37:7–12. 2010. View Article : Google Scholar : PubMed/NCBI
|
